These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10898316)

  • 1. A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma.
    Kwok PC; Lam TW; Chan SC; Chung CP; Wong WK; Chan MK; Lo HY; Lam WM
    J Hepatol; 2000 Jun; 32(6):955-64. PubMed ID: 10898316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatocellular carcinoma associated with advanced cirrhosis by transcatheter arterial chemoembolization using autologous blood clot: a preliminary report.
    Gunji T; Kawauchi N; Ohnishi S; Ishikawa T; Nakagama H; Kaneko T; Moriyama T; Matsuhashi N; Yazaki Y; Imawari M
    Hepatology; 1992 Feb; 15(2):252-7. PubMed ID: 1310476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of unresectable hepatocellular carcinoma less than 2 centimeters by transcatheter arterial chemoembolization with autologous blood clot.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    J Clin Gastroenterol; 2003 Apr; 36(4):347-51. PubMed ID: 12642743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
    Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
    Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
    Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
    J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of inoperable hepatocellular carcinoma patients receiving transarterial chemoembolisation: a real-life retrospective analysis in a Hong Kong regional hospital.
    Yip WM; Hung HG; Lok KH; Li KF; Li KK; Szeto ML
    Hong Kong Med J; 2009 Oct; 15(5):339-45. PubMed ID: 19801690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Pelletier G; Roche A; Ink O; Anciaux ML; Derhy S; Rougier P; Lenoir C; Attali P; Etienne JP
    J Hepatol; 1990 Sep; 11(2):181-4. PubMed ID: 2174933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
    Shi M; Lu LG; Fang WQ; Guo RP; Chen MS; Li Y; Luo J; Xu L; Zou RH; Lin XJ; Zhang YQ
    J Natl Cancer Inst; 2013 Jan; 105(1):59-68. PubMed ID: 23150720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of using different embolic agents on survival in transarterial chemoembolization of hepatocellular carcinoma: gelfoam versus polyvinyl alcohol.
    Koçyiğit A; Dicle O; Göktay Y; Astarcıoğlu I
    Diagn Interv Radiol; 2014; 20(4):323-9. PubMed ID: 24808440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
    Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
    Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam.
    Ngan H; Lai CL; Fan ST; Lai EC; Yuen WK; Tso WK
    Clin Radiol; 1993 May; 47(5):315-20. PubMed ID: 8389682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients.
    Markovic S; Gadzijev E; Stabuc B; Croce LS; Masutti F; Surlan M; Berden P; Brencic E; Visnar-Perovic A; Sasso F; Ferlan-Marolt V; Mucelli FP; Cesar R; Sponza M; Tiribelli C
    J Hepatol; 1998 Oct; 29(4):650-9. PubMed ID: 9824276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemoembolization in the treatment of hepatocarcinoma].
    Figueras J; Valls C; Pamies JJ; Benasco C; Sancho C; Rafecas A; Domínguez J; Torras J; Fabregat J; Baliellas C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):21-5. PubMed ID: 8383990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
    Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial chemotherapy using doxorubicin, iodized oil and Gelfoam embolization in hepatocellular carcinoma.
    Van Beers B; Roche A; Cauquil P; Jamart J; Pariente D; Ajavon Y
    Acta Radiol; 1989; 30(4):415-8. PubMed ID: 2550043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
    Lee JW; Oh JK; Chung YA; Na SJ; Hyun SH; Hong IK; Eo JS; Song BI; Kim TS; Kim DY; Kim SU; Moon DH; Lee JD; Yun M
    J Nucl Med; 2016 Apr; 57(4):509-16. PubMed ID: 26742711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.